Current marketplace for probiotics: A Japanese perspective

被引:32
作者
Amagase, Harunobu [1 ]
机构
[1] FreeLife Int, Phoenix, AZ 85040 USA
关键词
D O I
10.1086/523338
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In Japan, probiotics are available as both foods and drugs. Unlike in the United States, probiotics have a long history of cultural acceptance and safe use in Japan. Sales are booming, which may reflect the inception of the regulatory category "foods for specialized health use" (FOSHU), which permits labeling with claims that describe health benefits. A total of 65 probiotic products, containing 16 different strains, are listed among the 579 FOSHU products. Since the US market for probiotics is still small, it has substantial room to grow.
引用
收藏
页码:S73 / S75
页数:3
相关论文
共 18 条
[1]  
[Anonymous], PROBIOTICS SCI BASIS
[2]   Healthcare technology assessment and the challenge to pharmacoeconomics in Japan [J].
Hisashige, A .
PHARMACOECONOMICS, 1997, 11 (04) :319-333
[3]  
*HLTH CAR DIVG FUJ, 2006, FUJI KEIZAI, V16, P71
[4]  
HONMA N, 1986, NEW MED CLIN, V35, P2687
[5]  
ISHIBASHI N, 1993, FOOD TECHNOL-CHICAGO, V47, P126
[6]  
KAWAI K, 1967, CLIN RES, V44, P104
[7]  
Koyama W, 2000, METHOD INFORM MED, V39, P229
[8]   Assay procedures for commercial probiotic cultures [J].
McCann, T ;
Egan, T ;
Weber, GH .
JOURNAL OF FOOD PROTECTION, 1996, 59 (01) :41-45
[9]  
MITSUOKA T, 1975, CLIN BACTERIA, V2, P1
[10]   Health foods and foods with health claims in Japan [J].
Ohama, H ;
Ikeda, H ;
Moriyama, H .
TOXICOLOGY, 2006, 221 (01) :95-111